Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

S&P edges higher, oil advances as Senate considers expanded stimulus

Published 29/12/2020, 00:45
© Reuters. Passersby wearing protective face masks are reflected on a stock quotation board outside a brokerage, amid the coronavirus disease (COVID-19) outbreak, in Tokyo

By Stephen Culp

NEW YORK (Reuters) -Wall Street struggled on Tuesday to build on the previous session's record closing highs and crude oil gained ground as investors looked to Washington for signs that an enhanced stimulus package would pass a Senate vote.

The S&P 500 and the Dow pared early gains and the Nasdaq was flat as market participants balanced near-term challenges with longer-term hopes for economic recovery and a return to healthy demand.

"You have government economic assistance coupled with Brexit, which is pushing stocks up in Europe, Britain and the U.S.," said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia. "But you have the $2000 bonus passing the House and if the Senate doesn't, they look like Grinches.

"You have to take these days between the holidays with a grain of salt because there's limited liquidity," Tuz added.

The U.S. House of Representatives voted on Monday to meet President Donald Trump's demand for $2,000 direct payments to Americans as part of the recently signed fiscal relief bill, sending the measure to the Republican-controlled Senate.

Vaccine trials and distribution gather momentum around the world as global COVID-19 cases https://apac1.apps.cp.thomsonreuters.com/cms/?navid=1592404098 surpass 81 million and deaths approach 1.8 million. In the United States, there have been more than 19 million cumulative cases and nearly 335,000 deaths.

The Dow Jones Industrial Average fell 21.86 points, or 0.07%, to 30,382.11, the S&P 500 gained 3.27 points, or 0.09%, to 3,738.63 and the Nasdaq Composite dropped 1.91 points, or 0.01%, to 12,897.51.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

European stocks extended their year-end rally in the wake of the Brexit trade deal and as the European Union vaccination program got underway.

The pan-European STOXX 600 index rose 0.80% and MSCI's gauge of stocks across the globe gained 0.51%.

Emerging market stocks rose 1.01%. MSCI's broadest index of Asia-Pacific shares outside Japan closed 0.98% higher, while Japan's Nikkei rose 2.66%.

Crude prices advanced on the prospect of expanded pandemic aid, which could boost demand and spur economic growth.

U.S. crude rose 1.15% to $48.17 per barrel and Brent was last at $51.41 per barrel, up 1.06% on the day.

U.S. Treasury yields were little changed in choppy trading, and the yield curve was slightly steeper as investors awaited the Senate's response to the higher stimulus check approved by the House.[nL1N2J90RM]

Benchmark 10-year notes last fell 1/32 in price to yield 0.9347%, from 0.933% late on Monday.

The 30-year bond last fell 5/32 in price to yield 1.675%, from 1.669% late on Monday.

The dollar dipped and the euro gained ground as fiscal aid and the Brexit trade deal prompted forex traders to favor riskier currencies.

The dollar index fell 0.41%, with the euro up 0.25% to $1.2244.

The Japanese yen strengthened 0.22% versus the greenback at 103.58 per dollar, while Sterling was last trading at $1.3496, up 0.35% on the day.

Gold prices advanced as the dollar weakened on the prospect of more robust stimulus payments.

Spot gold added 0.4% to $1,878.58 an ounce.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.